Company news

Kiniksa Pharmaceuticals International, plc news in 2026

Kiniksa Pharmaceuticals International, plc's news releases, calls and decks from 2026, newest first.

View company

Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution

October 27, 2026

Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026

October 22, 2026

Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference

September 4, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

August 7, 2026

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

July 28, 2026

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

July 23, 2026

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

April 28, 2026

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

April 23, 2026

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

April 7, 2026

Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference

February 25, 2026

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution

February 24, 2026

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 19, 2026

Kiniksa Pharmaceuticals Provides Corporate Update

January 12, 2026

Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026

Calls in 2026

Decks in 2026